The core activity of PharmaBiome is the research and development of therapies in the field of the microbiome, particularly in the analysis and production of microbial technologies. The company focuses on developing solutions that improve the function of the microbiome and offers analytical and production-related technologies to this end.
AI-generated
Offering
Products & services
Industry:Research & Development
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Microbiome-based therapies for specific diseases, developed from disease biology; targeted bacterial consortia, bioreactor-based cultivation, and function-oriented mechanisms of action.
Development and production of function-based bacterial consortia
Function-based bacterial mixtures and multistrain networks, rationally assembled, co-cultivated and developed for scalable, GMP-compliant production.
Collaboration in microbiome R&D
Collaborations for microbiome research and the further development of functional bacterial consortia ; contact for scientific partners and organization-related requests.